| Companies sponsors |
UCB (fenfluramine hydrochloride) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Epilepsy Action |
| |
SUDEP Action |
| |
Tuberous Sclerosis Association |
| |
Young Epilepsy |
| Professional groups |
Association of British Neurologists |
| |
British Paediatric Epilepsy Group |
| |
British Paediatric Neurology Association |
| |
International League Against Epilepsy UK Chapter (ILAE) |
| |
Neonatal and Paediatric Pharmacists Group |
| |
Royal College of Physicians |
| Comparator companies |
Accord Healthcare – not participating |
| |
Aspire Pharma – not participating |
| |
Atnahs Pharma – not participating |
| |
Aurobindo Pharma – not participating |
| |
Desitin Pharma – not participating |
| |
Eisai – not participating |
| |
Gerot Lannach UK – not participating |
| |
GlaxoSmithKline – not participating |
| |
Glenmark Pharmaceuticals Europe – not participating |
| |
Janssen-Cilag – not participating |
| |
Jazz Pharmaceuticals (cannabidiol) |
| |
Martindale Pharma – not participating |
| |
Mylan – not participating |
| |
Rosemont Pharmaceuticals – not participating |
| |
Sanofi – not participating |
| |
Seacross Pharmaceuticals Ltd – not participating |
| |
Somex Pharma – not participating |
| |
Thame Laboratories – not participating |
| |
Viatris – not participating |
| |
Wockhardt – not participating |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department for Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |